Literature DB >> 10584211

Influence of berberine on T-cell mediated immunity.

N Ivanovska1, S Philipov, M Hristova.   

Abstract

The protoberberine alkaloid berberine is isolated as a main alkaloid from the roots and bark of Berberis vulgaris. Berberine strongly inhibited in vitro the proliferative response of mouse spleen cells to T-dependent mitogens concanavalin A (Con A) and phytochemagglutinin (PHA). Spleen cells obtained from berberine-treated mice (10 mg/kg/3 days) expressed enhanced proliferative response to both mitogens. Berberine was applied to mice at different intervals before or after the induction of adjuvant arthritis (AIA) and Candida albicans (C. albicans) infection. The application of the alkaloid to new born mice (5 days after birth at a dose of 5 mg/kg/3 days) did not change the course of AIA and C. albicans infection. Its application at three 10 day intervals (5 mg/kg), starting from the 5 day after birth increased the joint inflammation in AIA. The host resistance to C. albicans infection was not affected, while the delayed type hypersensitivity (DTH)-reaction against the pathogen was enhanced. The alkaloid inhibited the development of AIA when applied after its onset (10 mg/kg from day +3 to +12 day). Berberine treatment during the ongoing infection did not influence its outcome (from +2 to +10 day).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10584211     DOI: 10.3109/08923979909007141

Source DB:  PubMed          Journal:  Immunopharmacol Immunotoxicol        ISSN: 0892-3973            Impact factor:   2.730


  6 in total

Review 1.  Cancer prevention and therapy through the modulation of the tumor microenvironment.

Authors:  Stephanie C Casey; Amedeo Amedei; Katia Aquilano; Asfar S Azmi; Fabian Benencia; Dipita Bhakta; Alan E Bilsland; Chandra S Boosani; Sophie Chen; Maria Rosa Ciriolo; Sarah Crawford; Hiromasa Fujii; Alexandros G Georgakilas; Gunjan Guha; Dorota Halicka; William G Helferich; Petr Heneberg; Kanya Honoki; W Nicol Keith; Sid P Kerkar; Sulma I Mohammed; Elena Niccolai; Somaira Nowsheen; H P Vasantha Rupasinghe; Abbas Samadi; Neetu Singh; Wamidh H Talib; Vasundara Venkateswaran; Richard L Whelan; Xujuan Yang; Dean W Felsher
Journal:  Semin Cancer Biol       Date:  2015-04-10       Impact factor: 15.707

2.  In vitro biological assessment of Berberis vulgaris and its active constituent, berberine: antioxidants, anti-acetylcholinesterase, anti-diabetic and anticancer effects.

Authors:  Abeer E Abd El-Wahab; Doaa A Ghareeb; Eman E M Sarhan; Marwa M Abu-Serie; Maha A El Demellawy
Journal:  BMC Complement Altern Med       Date:  2013-09-05       Impact factor: 3.659

3.  Phellodendron and Citrus extracts benefit joint health in osteoarthritis patients: a pilot, double-blind, placebo-controlled study.

Authors:  Julius Oben; Ebangha Enonchong; Shil Kothari; Walter Chambliss; Robert Garrison; Deanne Dolnick
Journal:  Nutr J       Date:  2009-08-14       Impact factor: 3.271

4.  In vitro antioxidant effects of barberry fruit extracts.

Authors:  Durdi Qujeq; Solmaz Kamei
Journal:  Int J Mol Cell Med       Date:  2012

5.  Anti-arthritic activity of aqueous-methanolic extract and various fractions of Berberis orthobotrys Bien ex Aitch.

Authors:  Ambreen Malik Uttra; Umme Habiba Hasan
Journal:  BMC Complement Altern Med       Date:  2017-07-18       Impact factor: 3.659

Review 6.  Anti-Inflammatory and Immunomodulatory Effects of Barberry (Berberis vulgaris) and Its Main Compounds.

Authors:  Rasool Nasiri Kalmarzi; Seyyed Nima Naleini; Damoon Ashtary-Larky; Ilaria Peluso; Leila Jouybari; Alireza Rafi; Fereshteh Ghorat; Nishteman Heidari; Faezeh Sharifian; Jalal Mardaneh; Paola Aiello; Sobhan Helbi; Wesam Kooti
Journal:  Oxid Med Cell Longev       Date:  2019-11-19       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.